Akiram Therapeutics

Akiram Therapeutics is a pioneering biotechnology research company dedicated to advancing radiotherapeutics for the treatment of solid tumors. Committed to innovation, Akiram Therapeutics focuses on developing targeted molecular radiotherapy to provide new hope for patients facing incurable cancer. The company’s unique approach combines a radiation component with a proprietary antibody, ensuring radioactivity is delivered directly to cancer cells while minimizing harm to healthy tissues. Operating from its primary address in Uppsala, SE, Akiram Therapeutics leverages cutting-edge discoveries to transform cancer treatment.

At Akiram Therapeutics, the mission is to make targeted molecular radiotherapy widely accessible, recognizing the need for personalized approaches in cancer treatment. Through state-of-the-art radiopharmaceuticals and precision medicine, Akiram Therapeutics aims to create more effective and tailored treatments for individuals battling cancer. The company's commitment to scientific research and innovation drives its efforts to improve outcomes and enhance the quality of life for patients worldwide.

Akiram Therapeutics is poised to make significant strides in the field of oncology. This dedication to advancing cancer therapy ensures that Akiram Therapeutics remains at the forefront of biotechnology research. We invite the manager of Akiram Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and commercial potential.